Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Lynxkite is expanding its partnership with Biophytis SA (Euronext Growth Paris: ALBPS) ("Biophytis"), starting with the MASSIVE project (MAS Receptor Synthetic Innovation & Virtual Engineering for ...
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
Although nothing concrete was announced regarding the future on Wednesday from PGA Tour headquarters, new CEO Brian Rolapp spent the majority of his inaugural Players Championship press conference ...
CEO Jim Clemmer said the company has spent the last several years reshaping its portfolio and operating model, moving away ...
UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results